Cada Dennis J, Levien Terri L, Baker Danial E
Founder and Contributing Editor, The Formulary , Washington State University , Spokane, Washington.
Clinical Professor, Drug Information Center, Washington State University , Spokane, Washington.
Hosp Pharm. 2014 Jul;49(7):647-62. doi: 10.1310/hpj4907-647.
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The July 2014 monograph topics are albiglutide, ramucirumab, short ragweed pollen allergen extract, timothy grass pollen allergen extract, and isavuconazole. The DUE/MUE is on albiglutide.
《处方集专论服务》的订阅者每月会收到5至6篇关于新发布或处于3期临床试验后期阶段药物的详细记录专论。这些专论面向药学与治疗学委员会。订阅者每月还会收到1页关于对议程以及药房/护理在职培训有用药物的简要专论。每月还会提供一份全面的目标药物利用评估/用药使用评估（DUE/MUE）。订阅后，专论会以印刷形式发送，也可在线获取。专论可根据机构需求进行定制。现在每月会随《处方集专论服务》发布一份药物类别综述。通过《处方集》的合作，《医院药学》在本专栏发表精选综述。如需了解《处方集专论服务》的更多信息，请致电《处方集》800 - 322 - 4349。2014年7月的专论主题有阿必鲁肽、雷莫西尤单抗、短豚草花粉变应原提取物、梯牧草花粉变应原提取物和艾沙康唑。DUE/MUE针对阿必鲁肽。
